ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany
Ostermann H, Bruno B, Greiner W, Possinger K, Tesch H, Zaun S, Maass N (2011)
Onkologie 34: 61-62.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Ostermann, H.;
Bruno, B.;
Greiner, WolfgangUniBi;
Possinger, K.;
Tesch, H.;
Zaun, S.;
Maass, N.
Einrichtung
Erscheinungsjahr
2011
Serien- oder Zeitschriftentitel
Onkologie
Band
34
Seite(n)
61-62
ISSN
0378-584X
Page URI
https://pub.uni-bielefeld.de/record/2409537
Zitieren
Ostermann H, Bruno B, Greiner W, et al. ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany. Onkologie. 2011;34:61-62.
Ostermann, H., Bruno, B., Greiner, W., Possinger, K., Tesch, H., Zaun, S., & Maass, N. (2011). ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany. Onkologie, 34, 61-62.
Ostermann, H., Bruno, B., Greiner, Wolfgang, Possinger, K., Tesch, H., Zaun, S., and Maass, N. 2011. “ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany”, Onkologie, 34: 61-62.
Ostermann, H., Bruno, B., Greiner, W., Possinger, K., Tesch, H., Zaun, S., and Maass, N. (2011). ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany. Onkologie 34, 61-62.
Ostermann, H., et al., 2011. ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany. Onkologie, 34, p 61-62.
H. Ostermann, et al., “ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany”, Onkologie, vol. 34, 2011, pp. 61-62.
Ostermann, H., Bruno, B., Greiner, W., Possinger, K., Tesch, H., Zaun, S., Maass, N.: ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany. Onkologie. 34, 61-62 (2011).
Ostermann, H., Bruno, B., Greiner, Wolfgang, Possinger, K., Tesch, H., Zaun, S., and Maass, N. “ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany”. Onkologie 34 (2011): 61-62.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar